Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue: +19.2%
EPS: +64.1%
Free cash flow: −29.8%
Total debt: −5.19%

Quarter to September 2026, against a year earlier

145.49 10.63 −6.81%

Follow PODD

Alert me

Market cap: $10.8B
P/E: 25.2×
Fwd P/E: 24.4×
Dividend yield: —
F-score: 6/9
Altman Z: 9.09
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insulet Corporation (PODD) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Insulet Corporation (PODD) trades at a P/S ratio of 3.4×. Over the past ten years it has ranged from 2.8× (September 2026) to 21.1× (November 2021); the current reading is higher than 2% of that period. That is above the Medical Devices industry median of 2.5× and in line with the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PODD/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Insulet Corporation P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PODD/metrics/ps-ratio">Insulet Corporation (PODD) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	7.4×	(16.39%)
FY2024	8.8×	2.76%
FY2023	8.6×	(43.53%)
FY2022	15.2×	(7.15%)
FY2021	16.4×	(10.41%)
FY2020	18.3×	30.21%
FY2019	14.1×	69.70%
FY2018	8.3×	(4.04%)
FY2017	8.6×	48.10%
FY2016	5.8×	(28.39%)

Period	P/S ratio	Change
Sep 2026	2.8×	(17.88%)
Jun 2026	3.5×	(31.75%)
Mar 2026	5.1×	(31.43%)
Dec 2025	7.4×	(14.29%)
43 more quarters	Free account

Against its own ten years

Low 2.8× High 21.1×

Ten-year median 9.4×

Current reading's percentile 2

Company	P/S ratio
SNN Smith & Nephew SNATS, Inc. compare	1.4×
BRKR Bruker Corporation compare	2.5×
PODD Insulet Corporation	3.4×
GMED Globus Medical, Inc. compare	3.5×
BIO Bio-Rad Laboratories, Inc. compare	3.8×
BIO.B Bio-Rad Laboratories, Inc. compare	3.9×
PEN Penumbra, Inc. compare	8.1×
TXG 10x Genomics compare	12.4×
GKOS Glaukos Corporation compare	18.8×
Medical Devices industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Insulet Corporation (PODD) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on PODD

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on PODD

Stockrow Weekly